BioAtla (BCAB) Financial Statements

785 Followers

BioAtla Financial Overview

BioAtla's market cap is currently $6.12M. The company's EPS TTM is $-41.72; its P/E ratio is -0.48; BioAtla is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 2.00M	$ 11.00M	$ 0.00	$ 0.00	$ 250.00K
Gross Profit	$ 2.00M	$ 10.07M	$ -1.22M	$ -1.20M	$ 250.00K
Operating Income	$ -59.30M	$ -73.94M	$ -129.69M	$ -108.14M	$ -96.44M
EBITDA	$ -58.93M	$ -73.02M	$ -122.24M	$ -105.28M	$ -94.07M
Net Income	$ -59.61M	$ -69.78M	$ -123.46M	$ -105.28M	$ -95.40M
Balance Sheet
Cash & Short-Term Investments	$ 7.12M	$ 49.05M	$ 111.47M	$ 215.51M	$ 244.98M
Total Assets	$ 13.83M	$ 52.42M	$ 119.66M	$ 225.74M	$ 254.42M
Total Debt	$ 6.20M	$ 836.00K	$ 2.46M	$ 3.98M	$ 5.37M
Net Debt	$ -918.00K	$ -48.21M	$ -109.01M	$ -211.53M	$ -239.61M
Total Liabilities	$ 50.02M	$ 38.16M	$ 48.99M	$ 45.40M	$ 43.60M
Stockholders' Equity	$ -36.19M	$ 14.27M	$ 70.67M	$ 180.34M	$ 210.82M
Cash Flow
Free Cash Flow	$ -48.20M	$ -71.94M	$ -104.11M	$ -90.69M	$ -63.14M
Operating Cash Flow	$ -48.20M	$ -71.94M	$ -104.02M	$ -90.42M	$ -62.21M
Investing Cash Flow	$ 0.00	$ 0.00	$ -98.00K	$ -265.00K	$ -924.00K
Financing Cash Flow	$ 6.28M	$ 9.51M	$ 77.00K	$ 61.21M	$ 69.51M

Currency in USD

BioAtla Earnings and Revenue History

Income Statement >

BioAtla Debt to Assets

Balance Sheet >

BioAtla Cash Flow

Cash Flow >

BioAtla Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >